Anticancer Drug Development: Preclinical Screening, Clinical Trials and Approval

被引：0
|
作者：
D Selwood
机构：
[1] Wolfson Institute for Biomedical Research,
[2] University College,undefined
来源：
British Journal of Cancer | 2004年 / 91卷 / 5期
关键词：
D O I：
10.1038/sj.bjc.6602070
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1000 / 1000
相关论文
共 50 条
  • [21] Factors Affecting Drug-Development Strategies in Asian Global Clinical Trials for Drug Approval in Japan
    Asano, Kunihito
    Uyama, Yoshiaki
    Tohkin, Masahiro
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2018, 11 (02): : 182 - 188
  • [22] Mafosfamide as a New Anticancer Agent: Preclinical Investigations and Clinical Trials
    Mazur, Lidia
    Opydo-Chanek, Malgorzata
    Stojak, Marta
    Wojcieszek, Katarzyna
    ANTICANCER RESEARCH, 2012, 32 (07) : 2783 - 2789
  • [23] Phase 0 trials for anticancer drug development
    Nature Reviews Drug Discovery, 2009, 8 (6) : 442 - 442
  • [24] Characteristics of Clinical Trials for the US Food and Drug Administration Accelerated Approval and Subsequent Confirmatory Trials: Implications for Drug Approval in Japan
    Mamiya, Hiroaki
    Narukawa, Mamoru
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2024, 47 (07) : 1345 - 1349
  • [25] RESEARCH CHALLENGES, NEW DRUG DEVELOPMENT, PRECLINICAL AND CLINICAL-TRIALS IN THE AGING POPULATION
    ABERNETHY, DR
    DRUG SAFETY, 1990, 5 : 71 - 74
  • [26] Modelling in preclinical and clinical drug development
    Balant, LP
    Gex-Fabry, M
    PHARMACOKINETIC OPTIMIZATION IN DRUG RESEARCH: BIOLOGICAL, PHYSICOCHEMICAL, AND COMPUTATIONAL STRATEGIES, 2001, : 15 - 29
  • [27] End points in cancer clinical trials and the drug approval process
    Schilsky, RL
    CLINICAL CANCER RESEARCH, 2002, 8 (04) : 935 - 938
  • [28] Representation of older patients in clinical trials for drug approval in Japan
    Asahina, Y.
    Sugano, H.
    Sugiyama, E.
    Uyama, Y.
    JOURNAL OF NUTRITION HEALTH & AGING, 2014, 18 (05): : 520 - 523
  • [29] Preclinical and clinical trials of the new tuberculosis drug perchlozon
    Yablonskiy, P. K.
    Vinogradova, T. I.
    Levashev, Yu. N.
    Pavlova, M. V.
    Zilber, E. K.
    Starshinova, A. A.
    Sapozhnikova, N. V.
    Chernokhaeva, I. V.
    Archakova, L. I.
    Zabolotnykh, N. V.
    Vitovskaya, M. L.
    TERAPEVTICHESKII ARKHIV, 2016, 88 (03) : 111 - +
  • [30] Representation of older patients in clinical trials for drug approval in Japan
    Yasuko Asahina
    H. Sugano
    E. Sugiyama
    Y. Uyama
    The journal of nutrition, health & aging, 2014, 18 : 520 - 523
12345